Private company

Intelligent Medicine Acquisition Corp.

American blank check company, incorporated in Delaware1

In its 2023 annual report the company says: “We are a blank check company incorporated in Delaware on February 25, 2021 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Our Sponsor is Intelligent Medicine Sponsor LLC, a Delaware limited liability company.”25 It is headquartered in Bethesda, Maryland.1

Last updated Oct 20, 2026.

Overview

$11.4MNet income, fiscal 20222
  • IndustryBlank Checks1
  • HeadquartersBethesda, Maryland1
  • Incorporated inDE3
  • Business address9001 Burdette Rd., Bethesda, Md 208173
  • Filer category, Emerging growth company3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Fiscal year20212022
Operating expenses$1.3M2
Income before tax$12.0M2
Income tax$562.6K2
Net income$11.4M2

Compare Intelligent Medicine Acquisition Corp. with another company

Corporate structure

Intelligent Medicine Acquisition Corp. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Intelligent Medicine Acquisition Corp.

  • Saba Capital Management, L.P. Filed SC 13G/A on Intelligent Medicine Acquisition Corp., latest Apr 13, 2023 (4 filings since Nov 15, 2021)
  • Intelligent Medicine Sponsor LLC Filed SC 13D on Intelligent Medicine Acquisition Corp., latest Feb 21, 2023 (2 filings since Feb 11, 2022)
  • Sculptor Capital LP Filed SC 13G/A on Intelligent Medicine Acquisition Corp., latest Feb 14, 2022 (2 filings since Nov 12, 2021)
  • HIGHBRIDGE CAPITAL MANAGEMENT LLC Filed SC 13G/A on Intelligent Medicine Acquisition Corp., latest Jan 27, 2022 (2 filings since Nov 19, 2021)
  • Intelligent Medicine Acquisition Corp. Bethesda, Maryland

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Intelligent Medicine Acquisition Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$50.2K2 Dec 31, 2022$589.3K2 Dec 31, 2021−91.5%

Leadership

Who has led Intelligent Medicine Acquisition Corp., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Gregory C. Simon2021

Chief financial officer

  1. Gregory C. Simon2021
2025
Board members and other officers (5)

Timeline

  1. Apr 26, 20238-K Other events12
  2. Apr 7, 20238-K Listing notice or transfer13
  3. Apr 5, 20238-K Listing notice or transfer14
  4. Feb 23, 20238-K Entered a material agreement; New debt or obligation15
  5. Feb 9, 20238-K Bylaws or fiscal year changed; Shareholder vote16
  6. Feb 3, 20238-K Regulation FD disclosure17
  7. Dec 23, 20218-K Other events18
  8. Nov 16, 20218-K Other events19
  9. Nov 10, 20218-K Entered a material agreement; Unregistered sale of shares; Executive or director change20
  10. Nov 4, 2021New chief executive Gregory C. Simon becomes CEO7

Filings

56 filings to the SEC since October 2021: 2 annual reports, 4 quarterly reports, 9 major events, 11 insider forms, 10 large holders, 20 other. The latest 20:

  1. May 12, 202315-12G EDGAR
  2. Apr 27, 20233 FORM 3 SUBMISSION EDGAR
  3. Apr 26, 20238-K EDGAR
  4. Apr 17, 202310-K EDGAR
  5. Apr 13, 2023SC 13G/A EDGAR
  6. Apr 7, 20238-K EDGAR
  7. Apr 5, 20238-K EDGAR
  8. Apr 3, 2023NT 10-K EDGAR
  9. Feb 28, 20234 PRIMARY DOCUMENT EDGAR
  10. Feb 23, 2023425 EDGAR
  11. Feb 23, 20238-K EDGAR
  12. Feb 21, 2023SC 13D EDGAR
  13. Feb 10, 20234 OWNERSHIP DOCUMENT EDGAR
  14. Feb 9, 20238-K EDGAR
  15. Feb 3, 2023DEFA14A EDGAR
  16. Feb 3, 20238-K EDGAR
  17. Jan 27, 2023DEFA14A EDGAR
  18. Jan 19, 2023DEF 14A EDGAR
  19. Jan 18, 2023UPLOAD EDGAR
  20. Jan 17, 2023CORRESP EDGAR

The 56 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Intelligent Medicine Acquisition Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARIntelligent Medicine Acquisition Corp.1
  • CIK0001850051
  • Employer ID (EIN)86-22835271
  • Filer status<br>emerging growth company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)6770 Blank Checks1
  • SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance1
  • Business address9001 Burdette Rd., Bethesda, MD 208171
  • Phone202-905-58341
  • Public float$207.4M as of Jun 30, 20222
  • On EDGAR sinceMar 19, 20211
  • Filings63 in all: 8-K (9), 3 (8), SC 13G (6), SC 13G/A (5), 10-Q (4), CORRESP (3), UPLOAD (3), 10-K (2)1
    All 29 form types

    4 (2), DEFA14A (2), 15-12G (1), 25-NSE (1), 3/A (1), 424B4 (1), 425 (1), 8-A12B (1), CERT (1), DEF 14A (1), DRS (1), DRS/A (1), DRSLTR (1), EFFECT (1), NT 10-K (1), NT 10-Q (1), PRE 14A (1), S-1 (1), S-1/A (1), S-1MEF (1), SC 13D (1)

  • Latest filingsAnnual report (10-K) Apr 17, 2023
    Quarterly report (10-Q) Nov 14, 2022
    Proxy statement (DEF 14A) Jan 19, 2023
    Latest 8-K (8-K) Apr 26, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
    SEC EDGAROther events
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
    SEC EDGAROther events
  19. 19
    SEC EDGAROther events
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25